Table 2.
Study | Study Type | Major Domains | Minor Domains | OVERALL | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Recruitment & Follow-up (Cohort) | Exposure Definition & Measurement | Outcome Assessment & Validation | Con-Foun-Ding & Effect Modification | Analysis Method | Chronology | Assessor Blinding | Funding | Conflict of Interest | |||
Attarchi 2013 [48] | CS | ||||||||||
Brahem 2019 [49] | CS | ||||||||||
Chang 2009 [44] | CS | ||||||||||
Chang 2012 [50] | CS | ||||||||||
Chang 2013 [51] | Co | ||||||||||
Chen 2005 [52,63] | CS | ||||||||||
De Souza 2015 [53] | CS | ||||||||||
Fogari 1994 [54] § | CS | ||||||||||
Fogari 1995 [55] | CS | ||||||||||
Fokin 2018 [56] | Co | ||||||||||
Giordano 2001 [57] | CS | ||||||||||
Ha & Kim 1991 [58] | CS | ||||||||||
Hwang 2012 [59] | Co | ||||||||||
Jegaden 1986 [60] | CS | ||||||||||
Liu 2016 [61] | Co | ||||||||||
Melamed 2001 [62] | Co | ||||||||||
Parameswarappa 2015 [64] | CS | ||||||||||
Pilawska 1977 [65] | CS | ||||||||||
Shaykhlislamova 2018 [66] | CS | ||||||||||
Siagian 2009 [67] | Nested CC | ||||||||||
Souto Souza 2001 [68] | CS | ||||||||||
Stokholm 2013 [69] | Co | ||||||||||
Talijancic 1989 [70] | CS | ||||||||||
Zhao 1991 [71,72] | CS |
CS Cross-sectional; Co Cohort; CC Case-Control; Low Risk; Unclear Risk; High Risk; § not in meta-analysis.